Skip to main content
SpringerLink
Log in

Long-term outcomes following myeloablative allogeneic transplantation for multiple myeloma compared to autologous transplantation and the impact of graft-versus-myeloma effect

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Bensinger WI . Is there still a role for allogeneic stem-cell transplantation in multiple myeloma? Baillière's best practice & research. Clin Haematol 2007; 20: 783–795.

    CAS  Google Scholar 

  2. Miura Y, Azuma T, Kusumi E, Matsumura T, Kami M, Komatsu T . Graft-versus-myeloma effects in reduced-intensity cord blood transplantation. Int J Hematol 2007; 86: 463–465.

    Article  PubMed  Google Scholar 

  3. Barlogie B, Kyle RA, Anderson KC, Greipp PR, Lazarus HM, Hurd DD et al. Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321. J Clin Oncol 2006; 24: 929–936.

    Article  CAS  Google Scholar 

  4. Bruno B, Rotta M, Patriarca F, Mattei D, Allione B, Carnevale-Schianca F et al. Non-myeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo. Blood 2008; e-pub ahead of print December 8.

  5. Moreau P, Garban F, Attal M, Michallet M, Marit G, Hulin C et al. Long-term follow-up results of IFM99-03 and IFM99-04 trials comparing nonmyeloablative allotransplantation with autologous transplantation in high-risk de novo multiple myeloma. Blood 2008; 112: 3914–3915.

    Article  CAS  PubMed  Google Scholar 

  6. Bahlis NJ, Stewart DA, Savoie ML, Brown C, Daly A, Chaudhry A et al. Fludarabine-busulfan conditioning and in vivo T-cell depletion with reduced dose of ATG followed by allografting induces durable responses in patients with advanced multiple myeloma with no grade III–IV aGvHD. ASH Annual Meeting Abstracts 2006; 108: 3029.

    Google Scholar 

  7. Gahrton G, Svensson H, Cavo M, Apperly J, Bacigalupo A, Björkstrand B et al. Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983–1993 and 1994–1998 at European Group for Blood and Marrow Transplantation centres. Br J Haematol 2001; 113: 209–216.

    Article  CAS  PubMed  Google Scholar 

  8. Palumbo A, Rajkumar SV . Treatment of newly diagnosed myeloma. Leukemia 2008; e-pub ahead of print November 13.

Download references

Author information

Authors and Affiliations

  1. Department of Blood and Marrow Transplantation, University of Michigan, Ann Arbor, MI, USA

    Y Khaled, S Mellacheruvu, P Reddy, E Peres & S Mineishi

Authors
  1. Y Khaled
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Mellacheruvu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P Reddy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E Peres
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S Mineishi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Y Khaled.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khaled, Y., Mellacheruvu, S., Reddy, P. et al. Long-term outcomes following myeloablative allogeneic transplantation for multiple myeloma compared to autologous transplantation and the impact of graft-versus-myeloma effect. Bone Marrow Transplant 44, 325–326 (2009). https://doi.org/10.1038/bmt.2009.14

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2009.14

  • Springer Nature Limited

Search

Navigation